Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia
Public ClinicalTrials.gov record NCT00073164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study of the Safety and Efficacy of Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia
Study identification
- NCT ID
- NCT00073164
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Abbott
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- Divalproex Sodium Extended-Release Tablets Drug
- Olanzapine Drug
- Risperidone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2003
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Aug 3, 2006
Started 2003
United States locations
- U.S. sites
- 35
- U.S. states
- 18
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Tuscaloosa | Alabama | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Cerritos | California | — | — |
| Not listed | Chula Vista | California | — | — |
| Not listed | Garden Grove | California | — | — |
| Not listed | Glendale | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Gainsville | Florida | — | — |
| Not listed | Melbourne | Florida | — | — |
| Not listed | North Miami | Florida | — | — |
| Not listed | Winter Park | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Hoffman Estates | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | South Bend | Indiana | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Rockville | Maryland | — | — |
| Not listed | Jackson | Mississippi | — | — |
| Not listed | Clementon | New Jersey | — | — |
| Not listed | Kenilworth | New Jersey | — | — |
| Not listed | Holliswood | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Butner | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Irving | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Falls Church | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00073164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2006 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00073164 live on ClinicalTrials.gov.